PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Cannon, Christopher P.
TI  - DEFINE: CETP Inhibition with Anacetrapib Significantly Raises HDL Cholesterol and Further Lowers LDL
DP  - 2010  01
TA  - MD Conference Express
PG  - 13--14
VI  - 10
IP  - 10
4099  - http://mdc.sagepub.com/content/10/10/13.short
4100  - http://mdc.sagepub.com/content/10/10/13.full
AB  - This article discusses results from the Determining the Efficacy and Tolerability of CETP Inhibition with Anacetrapib [DEFINE; NCT00685776] trial, which showed that anacetrapib safely and substantially lowered LDL-C and raised HDL-C levels in patients with coronary heart disease.